Lipid substitution of mitochondrial monoamine oxidase can lead to the abolition of clorgyline selective inhibition without alteration in the A/B ratio assessed by substrate utilisation
- 1 December 1980
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 29 (23) , 3211-3213
- https://doi.org/10.1016/0006-2952(80)90589-4
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Exposure of mitochondrial outer membranes to neuraminidase selectively destroys monoamine oxidase A activityJournal of Pharmacy and Pharmacology, 1980
- Differences in A and B forms of monoamine oxidase revealed by limited proteolysis and peptide mappingNature, 1979
- The vectorial orientation of human monoamine oxidase in the mitochondrial outer membraneBiochemical Journal, 1979
- Monoamine oxidase A and B: A useful concept?Biochemical Pharmacology, 1978
- A model for the selective mode of action of the irreversible monoamine oxidase inhibitors clorgyline and deprenyl, based on studies of their ability to activate a Ca2+-Mg2+ ATPase in defined lipid environmentsJournal of Pharmacy and Pharmacology, 1977
- Multiple forms of monoamine oxidase: Fact and artefactLife Sciences, 1976
- Lipid phase transitions control β‐hydroxybutyrate dehydrogenase activity in defined‐lipid protein complexesFEBS Letters, 1975
- A kinetic evaluation of monoamine oxidase activity in rat liver mitochondrial outer membranesBiochemical Journal, 1974
- The nature of the electrophoretically separable multiple forms of rat liver monoamine oxidaseBiochemical Journal, 1973
- Some observations upon a new inhibitor of monoamine oxidase in brain tissueBiochemical Pharmacology, 1968